We found that the evaluations of PSA decision aids demonstrated, fairly consistently, an improvement in knowledge about PSA testing and prostate cancer; in contrast, however, no clear effect was found on PSA testing itself [5]. The gene discussed is KLK3; the disease is Familial prostate cancer.